Zydus Cadila's vaccine for children who are 12 years and above has an efficacy rate of 66%-67% among adults and 100% efficacy among children to date, says managing director Dr Sharvil Patel. The vaccine is due for launch next month.
"As of now, the interim efficacy for adults stands at 66-67%. For children, currently, the efficacy is 100%, but it’s not the way to look at it. You do a safety and immunogenicity study because you see higher antibodies in children, you will see the same efficacy as the hope. Maybe better, because Children have a better immune response,” Patel tells Fortune India.
ADVERTISEMENT